ellipticine and cp 31398

ellipticine has been researched along with cp 31398 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Deiry, WS; Wang, W	1
Dicker, DT; El-Deiry, WS; Hart, LS; Huang, C; Tavaluc, RT; Wang, W; Zhang, XM	1
Omar, SI; Tuszynski, J	1

Reviews

1 review(s) available for ellipticine and cp 31398

Article	Year
Restoration of p53 to limit tumor growth. Current opinion in oncology, 2008, Volume: 20, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Ellipticines; Genes, p53; Humans; Imidazoles; Models, Biological; Mutation; Neoplasms; Piperazines; Pyrimidines; Tumor Suppressor Protein p53	2008

Other Studies

2 other study(ies) available for ellipticine and cp 31398

Article	Year
The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells. Cancer biology & therapy, 2009, Volume: 8, Issue:22 Topics: Adenocarcinoma; Antineoplastic Agents; Colonic Neoplasms; DNA-Binding Proteins; Drug Synergism; Ellipticines; Fluorouracil; Genes, p53; Genes, Reporter; Genes, Synthetic; Genetic Vectors; Humans; Mutation; Neoplasm Proteins; Neoplastic Stem Cells; Nuclear Proteins; Pyrimidines; Receptors, TNF-Related Apoptosis-Inducing Ligand; Recombinant Fusion Proteins; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2009
Ranking the Binding Energies of p53 Mutant Activators and Their ADMET Properties. Chemical biology & drug design, 2015, Volume: 86, Issue:2 Topics: Alkylation; Amifostine; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Evaluation, Preclinical; Ellipticines; Heterocyclic Compounds, 4 or More Rings; Humans; Kinetics; Ligands; Mercaptoethylamines; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Mutation; Oxepins; Protein Binding; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53	2015

Article

Year

The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells.

Cancer biology & therapy, 2009, Volume: 8, Issue:22

Topics: Adenocarcinoma; Antineoplastic Agents; Colonic Neoplasms; DNA-Binding Proteins; Drug Synergism; Ellipticines; Fluorouracil; Genes, p53; Genes, Reporter; Genes, Synthetic; Genetic Vectors; Humans; Mutation; Neoplasm Proteins; Neoplastic Stem Cells; Nuclear Proteins; Pyrimidines; Receptors, TNF-Related Apoptosis-Inducing Ligand; Recombinant Fusion Proteins; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2009

Ranking the Binding Energies of p53 Mutant Activators and Their ADMET Properties.

Chemical biology & drug design, 2015, Volume: 86, Issue:2

Topics: Alkylation; Amifostine; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Evaluation, Preclinical; Ellipticines; Heterocyclic Compounds, 4 or More Rings; Humans; Kinetics; Ligands; Mercaptoethylamines; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Mutation; Oxepins; Protein Binding; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53

2015